Lisata Therapeutics (LSTA) Equity Ratio (2016 - 2025)
Lisata Therapeutics (LSTA) has disclosed Equity Ratio for 12 consecutive years, with 0.8 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Equity Ratio fell 8.78% year-over-year to 0.8, compared with a TTM value of 0.8 through Sep 2025, down 8.78%, and an annual FY2024 reading of 0.84, down 4.35% over the prior year.
- Equity Ratio was 0.8 for Q3 2025 at Lisata Therapeutics, down from 0.83 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.93 in Q2 2023 and bottomed at 0.8 in Q3 2025.
- Average Equity Ratio over 3 years is 0.87, with a median of 0.88 recorded in 2023.
- Peak annual rise in Equity Ratio hit 2.25% in 2025, while the deepest fall reached 8.78% in 2025.
- Year by year, Equity Ratio stood at 0.88 in 2023, then fell by 4.35% to 0.84 in 2024, then dropped by 4.67% to 0.8 in 2025.
- Business Quant data shows Equity Ratio for LSTA at 0.8 in Q3 2025, 0.83 in Q2 2025, and 0.87 in Q1 2025.